A new study shows, on one hand, strong activity, and on the other hand, challenging pharmacokinetics of new drug TAK-733 against colorectal cancer.
http://www.sciencedaily.com/releases/2015/10/151013175910.htm
TAK-733 shows challenge of using a promising drug in the human body
13 octubre 2015
Volver